首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Cell

缩写:CELL

ISSN:0092-8674

e-ISSN:1097-4172

IF/分区:42.5/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引9631
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Digvijay Singh,Neelesh Soni,Joshua Hutchings et al. Digvijay Singh et al.
The nuclear pore complex (NPC) is the sole mediator of nucleocytoplasmic transport. Despite great advances in understanding its conserved core architecture, the peripheral regions can exhibit considerable variation within and between specie...
Isabela Alvim,Carolina Silva-Carvalho,Marla Mendes de Aquino et al. Isabela Alvim et al.
More globally diverse perspectives are needed in genomic studies and precision medicine practices on non-Europeans. Here, we illustrate this by discussing the distribution of clinically actionable genetic variants involved in drug response ...
Hao Chang,Matthew H Perkins,Leonardo S Novaes et al. Hao Chang et al.
Negative psychological states impact immunity by altering the gut microbiome. However, the relationship between brain states and microbiome composition remains unclear. We show that Brunner's glands in the duodenum couple stress-sensitive b...
Anthony R Cillo,Carly Cardello,Feng Shan et al. Anthony R Cillo et al.
Relatlimab (rela; anti-LAG-3) plus nivolumab (nivo; anti-PD-1) is safe and effective for treatment of advanced melanoma. We designed a trial (NCT03743766) where advanced melanoma patients received rela, nivo, or rela+nivo to interrogate the...
Lawrence P Andrews,Samuel C Butler,Jian Cui et al. Lawrence P Andrews et al.
Overcoming immune-mediated resistance to PD-1 blockade remains a major clinical challenge. Enhanced efficacy has been demonstrated in melanoma patients with combined nivolumab (anti-PD-1) and relatlimab (anti-LAG-3) treatment, the first in ...
Shin Foong Ngiow,Sasikanth Manne,Yinghui Jane Huang et al. Shin Foong Ngiow et al.
Exhausted CD8 T (Tex) cells in chronic viral infection and cancer have sustained co-expression of inhibitory receptors (IRs). Tex cells can be reinvigorated by blocking IRs, such as PD-1, but synergistic reinvigoration and enhanced disease ...
Mikolaj Ogrodnik,Juan Carlos Acosta,Peter D Adams et al. Mikolaj Ogrodnik et al.
Cellular senescence is a cell fate triggered in response to stress and is characterized by stable cell-cycle arrest and a hypersecretory state. It has diverse biological roles, ranging from tissue repair to chronic disease. The development ...
Ruth J Parsons,Priyamvada Acharya Ruth J Parsons
The pre-fusion coronavirus HKU1 spike binds host sialoglycans and proteinaceous receptor TMPRSS2 for cell entry. In this issue of Cell, three papers by Fernández et al., McCallum et al., and Wang et al. provide structural information on HK...
Courtney T Kureshi,Michael Dougan,Stephanie K Dougan Courtney T Kureshi
LAG-3 is the third immune checkpoint pathway successfully targeted for cancer therapy. Although ineffective as a monotherapy, combination of LAG-3 and PD-1 blockade improves survival from advanced melanoma. In this issue of Cell, two studie...
Gonazalo Moratorio,Sannula Kesavardhana,Seema S Lakdawala et al. Gonazalo Moratorio et al.
H5N1 is an avian influenza virus that causes respiratory disease in birds and several land and sea mammals. The recent outbreak in the United States, including infection of dairy workers, has increased the concern around potential transmiss...